Ignite Creation Date:
2025-12-25 @ 4:41 AM
Ignite Modification Date:
2026-02-28 @ 2:29 PM
Study NCT ID:
NCT04822818
Status:
COMPLETED
Last Update Posted:
2022-12-28
First Post:
2021-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
EFFICACY and SAFETY OF BEVACIZUMAB (ZIRABEV®) IN PATIENTS WITH SEVERE HYPOXEMIC COVID-19
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Corona Virus Infection | View |
| None | SARS (Severe Acute Respiratory Syndrome) | View |
| None | Virus Diseases | View |
| None | Coronaviridae Infections | View |
| None | Nidovirales Infections | View |
| None | RNA Virus Infections | View |
| None | Respiratory Tract Infections | View |
| None | Respiratory Tract Diseases | View |